Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) Shares Shorted: Short Interest Up 76.0% in October

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 97,838 shares, an increase of 76.0% from the September 30th total of 55,588 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average trading volume of 86,848 shares, the days-to-cover ratio is presently 1.1 days.

Sernova Biotherapeutics Stock Down 4.4%

OTCMKTS:SEOVF opened at $0.08 on Friday. Sernova Biotherapeutics has a 52 week low of $0.06 and a 52 week high of $0.14. The company has a market capitalization of $28.66 million, a P/E ratio of -1.90 and a beta of 0.89. The stock’s fifty day moving average is $0.08 and its two-hundred day moving average is $0.10.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last announced its quarterly earnings results on Thursday, September 10th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01).

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies intended to treat chronic diseases by replacing or supplementing missing or dysfunctional cells. The company’s primary platform is the Cell Pouch System, an implantable device designed to create a vascularized environment that can house therapeutic cells and release biologically active substances into the body.

Sernova has focused its research and development activities on cell-based treatments for conditions including insulin-dependent diabetes, hemophilia A and hypothyroidism.